231 related articles for article (PubMed ID: 9307320)
41. Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.
Hamers FP; Wijbenga J; Wolters FL; Klis SF; Sluyter S; Smoorenburg GF
Audiol Neurootol; 2003; 8(6):305-15. PubMed ID: 14566101
[TBL] [Abstract][Full Text] [Related]
42. Hair cell regeneration after local application of gentamicin at the round window of the cochlea in the pigeon.
Müller M; Smolders JW
Hear Res; 1998 Jun; 120(1-2):25-36. PubMed ID: 9667428
[TBL] [Abstract][Full Text] [Related]
43. [Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats].
Fukaya H; Kanno H
Nihon Jibiinkoka Gakkai Kaiho; 1999 Jul; 102(7):907-17. PubMed ID: 10459293
[TBL] [Abstract][Full Text] [Related]
44. The origin of the low-frequency microphonic in the first cochlear turn of guinea-pig.
Patuzzi RB; Yates GK; Johnstone BM
Hear Res; 1989 May; 39(1-2):177-88. PubMed ID: 2737964
[TBL] [Abstract][Full Text] [Related]
45. Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs.
Teranishi M; Nakashima T; Wakabayashi T
Hear Res; 2001 Jan; 151(1-2):61-70. PubMed ID: 11124452
[TBL] [Abstract][Full Text] [Related]
46. The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study.
van Ruijven MW; de Groot JC; Klis SF; Smoorenburg GF
Hear Res; 2005 Jul; 205(1-2):241-8. PubMed ID: 15953532
[TBL] [Abstract][Full Text] [Related]
47. Dose response of carboplatin-induced hearing loss in rats: antioxidant defense system.
Husain K; Scott RB; Whitworth C; Somani SM; Rybak LP
Hear Res; 2001 Jan; 151(1-2):71-78. PubMed ID: 11124453
[TBL] [Abstract][Full Text] [Related]
48. A study of the ototoxicity of deferoxamine in chinchilla.
Shirane M; Harrison RV
J Otolaryngol; 1987 Dec; 16(6):334-9. PubMed ID: 3694744
[TBL] [Abstract][Full Text] [Related]
49. Time course of efferent fiber and spiral ganglion cell degeneration following complete hair cell loss in the chinchilla.
McFadden SL; Ding D; Jiang H; Salvi RJ
Brain Res; 2004 Jan; 997(1):40-51. PubMed ID: 14715148
[TBL] [Abstract][Full Text] [Related]
50. Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane.
Jie H; Tao S; Liu L; Xia L; Charko A; Yu Z; Bance M; Yin S; Robertson GS; Wang J
Gene Ther; 2015 Jul; 22(7):546-52. PubMed ID: 25809464
[TBL] [Abstract][Full Text] [Related]
51. Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.
Li Y; Ding D; Jiang H; Fu Y; Salvi R
Neurotox Res; 2011 Nov; 20(4):307-19. PubMed ID: 21455790
[TBL] [Abstract][Full Text] [Related]
52. The role of peroxiredoxin I in cisplatin-induced ototoxicity.
Le Q; Tabuchi K; Warabi E; Hara A
Auris Nasus Larynx; 2017 Apr; 44(2):205-212. PubMed ID: 27318370
[TBL] [Abstract][Full Text] [Related]
53. Trimethyltin disrupts loudness recruitment and auditory threshold sensitivity in guinea pigs.
Liu Y; Fechter LD
Neurotoxicol Teratol; 1995; 17(3):281-7. PubMed ID: 7623738
[TBL] [Abstract][Full Text] [Related]
54. Time response of carboplatin-induced hearing loss in rat.
Husain K; Scott B; Whitworth C; Rybak LP
Hear Res; 2004 May; 191(1-2):110-8. PubMed ID: 15109710
[TBL] [Abstract][Full Text] [Related]
55. Candidate's thesis: enhancing intrinsic cochlear stress defenses to reduce noise-induced hearing loss.
Kopke RD; Coleman JK; Liu J; Campbell KC; Riffenburgh RH
Laryngoscope; 2002 Sep; 112(9):1515-32. PubMed ID: 12352659
[TBL] [Abstract][Full Text] [Related]
56. The potential use of low-frequency tones to locate regions of outer hair cell loss.
Kamerer AM; Diaz FJ; Peppi M; Chertoff ME
Hear Res; 2016 Dec; 342():39-47. PubMed ID: 27677389
[TBL] [Abstract][Full Text] [Related]
57. Circadian vulnerability of cisplatin-induced ototoxicity in the cochlea.
Tserga E; Moreno-Paublete R; Sarlus H; Björn E; Guimaraes E; Göritz C; Cederroth CR; Canlon B
FASEB J; 2020 Oct; 34(10):13978-13992. PubMed ID: 32840016
[TBL] [Abstract][Full Text] [Related]
58. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
Watanabe H; Kanno H
Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
[TBL] [Abstract][Full Text] [Related]
59. Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology.
Böheim K; Bichler E
Arch Otorhinolaryngol; 1985; 242(1):1-6. PubMed ID: 4041173
[TBL] [Abstract][Full Text] [Related]
60. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
García-Berrocal JR; Nevado J; González-García JA; Sánchez-Rodríguez C; Sanz R; Trinidad A; España P; Citores MJ; Ramírez-Camacho R
J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
